XNCR

Xencor, Inc. is an innovative clinical-stage biopharmaceutical company based in Monrovia, California, focused on the creation of advanced cytokine and monoclonal antibody therapies to address significant unmet medical needs in oncology and autoimmune diseases. Utilizing its proprietary XmAb technology platform, the company enhances the therapeutic efficacy and safety of its drug candidates, positioning itself effectively within the competitive biopharmaceutical sector. With a promising and diversified pipeline nearing clinical advancement, Xencor is poised to deliver groundbreaking solutions aimed at improving patient outcomes, presenting compelling opportunities for institutional investors seeking exposure in the biopharmaceutical arena.